
Robert C. Boyle
Examiner (ID: 9565, Phone: (571)270-7347 , Office: P/1764 )
| Most Active Art Unit | 1764 |
| Art Unit(s) | 1764, 1796 |
| Total Applications | 1334 |
| Issued Applications | 896 |
| Pending Applications | 89 |
| Abandoned Applications | 374 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5028059
[patent_doc_number] => 20070269506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Oral Sustained Release Pharmaceutical Composition'
[patent_app_type] => utility
[patent_app_number] => 10/556641
[patent_app_country] => US
[patent_app_date] => 2004-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 3661
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20070269506.pdf
[firstpage_image] =>[orig_patent_app_number] => 10556641
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556641 | Oral sustained release pharmaceutical composition | May 18, 2004 | Issued |
Array
(
[id] => 4970806
[patent_doc_number] => 20070110808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'Extended release osmo-microsealed formulation'
[patent_app_type] => utility
[patent_app_number] => 10/563631
[patent_app_country] => US
[patent_app_date] => 2004-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5386
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20070110808.pdf
[firstpage_image] =>[orig_patent_app_number] => 10563631
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/563631 | Extended release osmo-microsealed formulation | May 13, 2004 | Abandoned |
Array
(
[id] => 5699662
[patent_doc_number] => 20060216346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Dosage form containing (s)-pantoprazole as active ingredient'
[patent_app_type] => utility
[patent_app_number] => 10/555331
[patent_app_country] => US
[patent_app_date] => 2004-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10203
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20060216346.pdf
[firstpage_image] =>[orig_patent_app_number] => 10555331
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555331 | Dosage form containing (s)-pantoprazole as active ingredient | May 6, 2004 | Abandoned |
Array
(
[id] => 5921593
[patent_doc_number] => 20060240100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Dosage form containing pantoprazole as active ingredient'
[patent_app_type] => utility
[patent_app_number] => 10/555238
[patent_app_country] => US
[patent_app_date] => 2004-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10303
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20060240100.pdf
[firstpage_image] =>[orig_patent_app_number] => 10555238
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555238 | Dosage form containing pantoprazole as active ingredient | May 6, 2004 | Abandoned |
Array
(
[id] => 5887475
[patent_doc_number] => 20060275235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Cation-modified galactomannan polysaccharide and cosmetic composition containing the same'
[patent_app_type] => utility
[patent_app_number] => 10/554874
[patent_app_country] => US
[patent_app_date] => 2004-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17785
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20060275235.pdf
[firstpage_image] =>[orig_patent_app_number] => 10554874
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/554874 | Cation-modified galactomannan polysaccharide and cosmetic composition containing the same | May 6, 2004 | Abandoned |
Array
(
[id] => 5074876
[patent_doc_number] => 20070014851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts'
[patent_app_type] => utility
[patent_app_number] => 10/555354
[patent_app_country] => US
[patent_app_date] => 2004-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3060
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20070014851.pdf
[firstpage_image] =>[orig_patent_app_number] => 10555354
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/555354 | Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts | May 2, 2004 | Issued |
Array
(
[id] => 4999409
[patent_doc_number] => 20070042043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Pellet formulations of acid-labile benzimidazonle compounds'
[patent_app_type] => utility
[patent_app_number] => 10/554727
[patent_app_country] => US
[patent_app_date] => 2004-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3332
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20070042043.pdf
[firstpage_image] =>[orig_patent_app_number] => 10554727
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/554727 | Pellet formulations of acid-labile benzimidazonle compounds | Apr 26, 2004 | Abandoned |
Array
(
[id] => 6966075
[patent_doc_number] => 20050232972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Drug delivery via punctal plug'
[patent_app_type] => utility
[patent_app_number] => 10/825047
[patent_app_country] => US
[patent_app_date] => 2004-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1379
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20050232972.pdf
[firstpage_image] =>[orig_patent_app_number] => 10825047
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/825047 | Drug delivery via punctal plug | Apr 14, 2004 | Abandoned |
Array
(
[id] => 7347581
[patent_doc_number] => 20040192763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'NMDA NR2B antagonists for treatment'
[patent_app_type] => new
[patent_app_number] => 10/821526
[patent_app_country] => US
[patent_app_date] => 2004-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9778
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192763.pdf
[firstpage_image] =>[orig_patent_app_number] => 10821526
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/821526 | NMDA NR2B antagonists for treatment | Apr 8, 2004 | Abandoned |
Array
(
[id] => 7346908
[patent_doc_number] => 20040192660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Protocol for improving vision'
[patent_app_type] => new
[patent_app_number] => 10/820264
[patent_app_country] => US
[patent_app_date] => 2004-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1561
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192660.pdf
[firstpage_image] =>[orig_patent_app_number] => 10820264
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/820264 | Protocol for improving vision | Apr 7, 2004 | Abandoned |
Array
(
[id] => 7018854
[patent_doc_number] => 20050220873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist'
[patent_app_type] => utility
[patent_app_number] => 10/815926
[patent_app_country] => US
[patent_app_date] => 2004-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11563
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20050220873.pdf
[firstpage_image] =>[orig_patent_app_number] => 10815926
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/815926 | Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist | Apr 1, 2004 | Abandoned |
Array
(
[id] => 7018723
[patent_doc_number] => 20050220742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Compositions and methods for maintaining eyelid hygiene'
[patent_app_type] => utility
[patent_app_number] => 10/816513
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6048
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20050220742.pdf
[firstpage_image] =>[orig_patent_app_number] => 10816513
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/816513 | Compositions and methods for maintaining eyelid hygiene | Mar 30, 2004 | Abandoned |
Array
(
[id] => 5807312
[patent_doc_number] => 20060093666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Formulations for tyrosine kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/544213
[patent_app_country] => US
[patent_app_date] => 2004-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4039
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20060093666.pdf
[firstpage_image] =>[orig_patent_app_number] => 10544213
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/544213 | Formulations for tyrosine kinase inhibitors | Mar 22, 2004 | Abandoned |
Array
(
[id] => 4651106
[patent_doc_number] => 20080038362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Composition For An Enteric Coating Of Natural Product Containing Lectin'
[patent_app_type] => utility
[patent_app_number] => 10/559988
[patent_app_country] => US
[patent_app_date] => 2004-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6918
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20080038362.pdf
[firstpage_image] =>[orig_patent_app_number] => 10559988
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/559988 | Composition For An Enteric Coating Of Natural Product Containing Lectin | Mar 18, 2004 | Abandoned |
Array
(
[id] => 5694805
[patent_doc_number] => 20060154952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation-and ummunologically-mediated diseases'
[patent_app_type] => utility
[patent_app_number] => 10/547185
[patent_app_country] => US
[patent_app_date] => 2004-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7321
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20060154952.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547185
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547185 | Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammation-and ummunologically-mediated diseases | Mar 15, 2004 | Abandoned |
Array
(
[id] => 7316840
[patent_doc_number] => 20040224017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Process for preparing sustained release tablets'
[patent_app_type] => new
[patent_app_number] => 10/800984
[patent_app_country] => US
[patent_app_date] => 2004-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9024
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224017.pdf
[firstpage_image] =>[orig_patent_app_number] => 10800984
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/800984 | Process for preparing sustained release tablets | Mar 14, 2004 | Abandoned |
Array
(
[id] => 7345839
[patent_doc_number] => 20040247674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Drug delivery system'
[patent_app_type] => new
[patent_app_number] => 10/487992
[patent_app_country] => US
[patent_app_date] => 2004-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7760
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20040247674.pdf
[firstpage_image] =>[orig_patent_app_number] => 10487992
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/487992 | Drug delivery system | Mar 11, 2004 | Abandoned |
Array
(
[id] => 5595830
[patent_doc_number] => 20060159746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Compositions comprising fatty acids and amino acids'
[patent_app_type] => utility
[patent_app_number] => 10/546942
[patent_app_country] => US
[patent_app_date] => 2004-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11185
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20060159746.pdf
[firstpage_image] =>[orig_patent_app_number] => 10546942
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/546942 | Compositions comprising fatty acids and amino acids | Feb 22, 2004 | Abandoned |
Array
(
[id] => 5687854
[patent_doc_number] => 20060286169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Lipophilic compositions'
[patent_app_type] => utility
[patent_app_number] => 10/545416
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3813
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20060286169.pdf
[firstpage_image] =>[orig_patent_app_number] => 10545416
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/545416 | Lipophilic compositions | Feb 12, 2004 | Abandoned |
Array
(
[id] => 5595732
[patent_doc_number] => 20060159648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Novel therapeutic method and compositions for topical administration'
[patent_app_type] => utility
[patent_app_number] => 10/545773
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13720
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20060159648.pdf
[firstpage_image] =>[orig_patent_app_number] => 10545773
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/545773 | Novel therapeutic method and compositions for topical administration | Feb 12, 2004 | Abandoned |